Hopp til innhold
c-myc
  • Hjem
  • Om oss
    • Hendelser
    • C-MYC Styre og Organisering
    • Faglig råd
    • Samarbeidspartnere
    • Kontakt
  • For pasienter
  • Forskning
    • Kliniske forkninsstudier
    • Research projects connected to the biobank
    • Publikasjoner Bjørn Tore Gjertsen
    • Publikasjoner Simona Chera
    • Publikasjoner Eivind Valen
  • Gjertsen Lab
  • Chera Lab
  • Valen Lab

Author: Tuyen Hoang

Oriol Castells and Stein-Erik Gullaksen at the Meet-the-Expert (MTE) – EHA2026 Congress in Stockholm

Postet 16. juni 202616. juni 2026 av Tuyen Hoang

Congratulations to Oriol Castells and Stein-Erik Gullaksen for their excellent cutting-edge research work presented at EHA2026 Congress in Stockholm (June 11–14, 2026). Both were chosen to be among the experts LES MER

Postet i News
Recap: Workshop "Statistics in Clinical Studies"

Recap: Workshop “Statistics in Clinical Studies”

Postet 18. mai 2026 av Tuyen Hoang

On May 7–8th 2026, the K.G. Jebsen Centre for Myeloid Blood Cancer CMYC, led by Professor Bjørn Tore Gjertsen, organized for the first time an interactive workshop on the topic LES MER

Postet i News
VITAL-CML trial has started with the first patient

VITAL-CML trial has started with the first patient

Postet 27. april 202611. mai 2026 av Tuyen Hoang

For the first time in the world, a patient with chronic leukemia is being injected with cancer cells in the hope of becoming cancer‑free as posted on nrk.no and on LES MER

Postet i News
CMYC and CCBIO Joint Seminar - Richard Dillon

CMYC and CCBIO Joint Seminar – Richard Dillon

Postet 13. april 202613. april 2026 av Tuyen Hoang

Welcome to the CMYC and CCBIO joint seminar. Speaker: Richard Dillon, Clinical Senior Lecturer in Cancer Genetics in the Department of Medical & Molecular Genetics, School of Basic & Medical LES MER

Postet i News
Posts navigation
Older posts →
← Newer posts

Upcoming Events

Notice
There are no upcoming hendelser.
MORE NEWS

The First CML Patient Received Vididencel Vaccine NRK news, NRK TV

"HUVAMER receives TMF funding for AML research" - CCBIO Newsletter October 2025

Support from the Norwegian Cancer Society 2024

New Hope for CML patients

Direktør

Bjørn Tore Gjertsen

Professor, MD PhD

Meddirektør

Simona Chera

Professor, Ph.D

Arkiv

EXTERNAL LINKS

The Research Council of Norway

The Norwegian Cancer Society

The Trond Mohn Research Foundation

Nordic AML Group

Nordic CML Study Group

The HOVON (Stichting Hemato-Oncologie voor Volwassenen Nederland)

CCBIO - Center for Cancer Biomarkers

Theme by Out the Box
Logg inn
en_USEN
en_USEN